FDA designates TERN-701 as breakthrough therapy for heavily pretreated Ph+ CP-CML, as allosteric BCR-ABL inhibitor shows ...
4P004 is a GLP-1 analog specifically engineered for intra-articular administration in the knee. It is designed to leverage the pleiotropic properties of GLP-1, including analgesic, anti-inflammatory, ...
Kymera Therapeutics, Inc. is among the best biotech stocks. TheFly reported on April 13 that KYMR announced that the U.S.
Roth conversions have become one of the most aggressively marketed planning strategies in the advisory business, but the industry’s understanding of when they work for a client and when they don’t ...
Businesses, schools, houses of faith, and non-profit organizations that engage the well-being of their employees, are transforming the state into a place where everyone can enjoy a healthy future.